MXCT (NASDAQ:MXCT) reported fourth quarter earnings that beat analyst expectations, but saw revenue plummet 45% YoY, sending shares down 10.4% in after-hours trading.MaxCyte, Inc. stock forum
MXCT (NASDAQ:MXCT) reported fourth quarter earnings that beat analyst expectations, but saw revenue plummet 45% YoY, sending shares down 10.4% in after-hours trading.